Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial
Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.
Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page
- Check4 days agoChange DetectedAdded a comprehensive list of study locations across multiple regions (California, Florida, Minnesota, Nebraska, Nevada, New York, North Carolina, Ohio, Pennsylvania, Texas; New South Wales, Queensland; Ontario, Quebec) under Locations. Updated the revision tag from v3.3.2 to v3.3.3 and removed the prior version indicator.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ARCHES-2 study record adds many new research sites worldwide and updates open-label extension timepoints and additional lipid endpoints.SummaryDifference2%
- Check26 days agoChange DetectedA new site revision label 'Revision: v3.3.2' appears and the previous 'Revision: v3.3.1' label is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check33 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not be about the study. The page revision is updated to v3.3.1.SummaryDifference0.1%
- Check40 days agoChange DetectedRemoved the government funding lapse notice about page updates and NIH operating status from the study details page.SummaryDifference0.3%
- Check55 days agoChange DetectedStudy record content and structure appear unchanged between versions; no new or removed sections or fields were detected.SummaryDifference0.3%
Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.